Indeed, tumour cells with BRAF mutations are addicted to ERK1/2 signalling for repression of BIM 58 and pharmacological inhibition of ERK1/2 signalling induces strong increases in BIM expression in many contexts. Here, MAPK3 is linked to neoplasm.